Your account is not claimed yet. You can sign up with ORCID to claim your account.

Juan Jose Lasarte (Juan J Lasarte, J J Lasarte, Juan José Lasarte, Juan Lasarte)

Loop profile Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 28

Top Venues

Nature medicine

Journal for immunotherapy of cancer

Journal of immunology (Baltimore, Md. : 1950)

Cancers

Centro de Investigación Médica Aplicada

Universidad de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro de Investigación Médica Aplicada Oct 1o 2002

Spain

Director :: Programa de Inmunología e Inmunoterapia

Education History

Universidad de Navarra Jan 8o 1988 - Dec 18o 1992

Spain

PHD :: Medicina Interna

Publications

Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine (2023)
Laura Perucho, Laura Icardi, Elisabetta Di Simone, Veronica Basso, Alessandra Agresti, Amaia Vilas Zornoza, Teresa Lozano, Felipe Prosper, Juan Jose Lasarte, Anna Mondino
The transcriptional regulator Sin3A balances IL-17A and Foxp3 expression in primary CD4 T cells. EMBO reports (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Ana Isabel Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona, Ester Blanco, Miren Zuazo, Maider Garnica, Luisa Chocarro, Elvira Alfaro-Arnedo, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Ana Remirez, Miriam Echaide, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Alejandra Roncero, Carolina Gotera, Alfonso Ventura, Nerea Recalde, José G Pichel, Juan Jose Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer. EMBO reports (2023)
Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero-Abraham, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteiza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Alejandro Javier Nicola Candia, Matías Garcia Fallit, Jorge A Peña Agudelo, Melanie Pérez Küper, Nazareno Gonzalez, Mariela A Moreno Ayala, Emilio De Simone, Carla Giampaoli, Noelia Casares, Adriana Seilicovich, Juan Jose Lasarte, Flavia A Zanetti, Marianela Candolfi
Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer. Viruses 15 (9) (2023)
Noelia Casares, Mar Cuadrado-Tejedor, Ana García-Osta, Juan Jose Lasarte
The immune system: uncharted pathways between senses and the brain. Neural regeneration research 19 (6) (2023)
Celia Martín-Otal, Aritz Lasarte-Cia, Diego Serrano, Noelia Casares, Enrique Conde, Flor Navarro, Inés Sánchez-Moreno, Marta Gorraiz, Patricia Sarrión, Alfonso Calvo, Carlos E De Andrea, José Echeveste, Amaia Vilas, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Sandra Hervás-Stubbs, Juan Jose Lasarte, Teresa Lozano
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. Journal for immunotherapy of cancer 10 (8) (2022)
Enrique Conde, Enric Vercher, Marta Soria-Castellano, Jesús Suarez-Olmos, Uxua Mancheño, Edurne Elizalde, M Luis Rodriguez, Javier Glez-Vaz, Noelia Casares, Estefanía Rodríguez-García, Mirja Hommel, Gloria González-Aseguinolaza, Iratxe Uranga-Murillo, Julian Pardo, Gorka Alkorta, Ignacio Melero Bermejo, Juan Jose Lasarte, Sandra Hervás-Stubbs
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants. Journal for immunotherapy of cancer 9 (11) (2022)
Flor Navarro, Noelia Casares, Celia Martín-Otal, Aritz Lasarte-Cía, Marta Gorraiz, Patricia Sarrión, Diana Llopiz, David Repáraz, Nerea Varo, Juan Roberto Rodriguez-Madoz, Felipe Prosper, Sandra Hervás-Stubbs, Teresa Lozano, Juan Jose Lasarte
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy. Oncoimmunology 11 (1) (2022)
Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, Ana Isabel Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo, Sergio Piñeiro-Hermida, Pablo Ramos, Juan Jose Lasarte, Ruth Vera, Grazyna Kochan, David Escors
CAR-T Cells for the Treatment of Lung Cancer. Life (Basel, Switzerland) 12 (4) (2022)
Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Guillermo Serrano, Marta Garrote, Maria L Palacios-Berraquero, Angel Martin-Mallo, Cristina Calviño-Sampedro, Marta Español-Rego, Candela Ceballos, Teresa Lozano, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Patricia Jauregui, Diego Alignani, María Cruz Viguria, Margarita Redondo, Mariona Pascal, Beatriz Martin-Antonio, Manel Juan, Alvaro Urbano-Ispizua, Paula Rodriguez-Otero, Ana Alfonso, Juan José Lahuerta, Juan Jose Lasarte, Susana Inoges, Ascensión López-Díaz de Cerio, Jesús San F Miguel, Carlos Fernández de Larrea, Mikel Hernaez, Juan Roberto Rodriguez-Madoz, Felipe Prosper
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Science advances 8 (39) (2022)
Esther Redin, Irati Garmendia, Teresa Lozano, Diego Serrano, Yaiza Senent, Miriam Redrado, Maria Villalba, Carlos E De Andrea, Francisco Expósito, Daniel Ajona, Sergio Ortiz-Espinosa, Ana Remirez, Cristina Bertolo, Cristina Sainz, Juana Garcia-Pedrero, Ruben Pio, Juan Jose Lasarte, Jackeline Agorreta, Luis M Montuenga, Alfonso Calvo
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Journal for immunotherapy of cancer 9 (3) (2021)
Ester Gonzalez-Sanchez, Javier Vaquero, Maite G Férnandez-Barrena, Juan Jose Lasarte, Matias A Avila, Pablo Sarobe, Maria Reig, Mariona Calvo, Isabel Fabregat
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma? Cancers 13 (13) (2021)
Teresa Lozano, Noelia Casares, Celia Martil-Otal, Blanca Anega, Marta Gorraiz, Jonathan Parker, Marta Ruiz, Virginia Belsúe, Antonio Pineda-Lucena, Julen Oyarzabal, Juan Jose Lasarte
Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor. Biomedicines 9 (2) (2021)
Belén Aparicio, Noelia Casares, Josune Egea, Marta Ruiz, Diana Llopiz, Sheila Maestro, Cristina Olagüe, Gloria Gonzalez Aseguinolaza, Cristian Smerdou, Ascensión López-Díaz de Cerio, Susana Inogés, Felipe Prosper, José Ramón Yuste, Francisco Carmona-Torre, Gabriel Reina, Juan Jose Lasarte, Pablo Sarobe
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses. Emerging microbes & infections 10 (1) (2021)
Aritz Lasarte-Cía, Teresa Lozano, David Cano, Celia Martín-Otal, Flor Navarro, Marta Gorraiz, Noelia Casares, Isabel Vivas, Juan Jose Lasarte
Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma. BioMed research international 2021 (2021)
Laura Arribillaga, Iciar Echeverria, Viriginia Belsue, Timothy Gomez, Teresa Lozano, Noelia Casares, Lorea Villanueva, Sonia Domingos-Pereira, Pedro J Romero, Denise Nardelli-Haefliger, Sandra Hervás-Stubbs, Pablo Sarobe, María Josefa Rodriguez, José L Carrascosa, Thomas Zürcher, Juan Jose Lasarte
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens. Journal for immunotherapy of cancer 8 (1) (2021)
Iosune Baraibar, Marta Roman, María Rodríguez-Remírez, Inés López, Anna Vilalta, Elisabeth Guruceaga, Margarita Ecay, María Collantes, Teresa Lozano, Diego Alignani, Ander Puyalto, Ana Oliver, Sergio Ortiz-Espinosa, Haritz Moreno, María Torregrosa, Christian Rolfo, Christian Caglevic, David García-Ros, María Villalba-Esparza, Carlos De Andrea, Silvestre Vincent, Rubén Pío, Juan Jose Lasarte, Alfonso Calvo, Daniel Ajona, Ignacio Gil-Bazo
Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells. Cancers 12 (11) (2020)
Daniel Ajona, Sergio Ortiz-Espinosa, Teresa Lozano, Francisco Expósito, Alfonso Calvo, Karmele Valencia, Miriam Redrado, Ana Remírez, Fernando Lecanda, Diego Alignani, Juan Jose Lasarte, Irati Macaya, Yaiza Senent, Cristina Bértolo, Cristina Sainz, Ignacio Gil-Bazo, Iñaki Eguren-Santamaría, Jose M Lopez-Picazo, Alvaro Gonzalez, José Luis Pérez-Gracia, Carlos E de Andrea, Silvestre Vincent, Miguel F Sanmamed, Luis M Montuenga, Ruben Pio
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade. Nature cancer 1 (1) (2020)
Marta Ivars, A España, P Alzuguren, Beatriz Pelacho, Juan Jose Lasarte, M J López-Zabalza
The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient. The British journal of dermatology 182 (5) (2019)
Cristina Segovia, Edurne San José-Enériz, Ester Munera-Maravilla, Mónica Martínez-Fernández, Leire Garate, Estíbaliz Miranda, Amaia Vilas-Zornoza, Iris Lodewijk, Carolina Rubio, Carmen Segrelles, Luis Vitores Valcárcel, Obdulia Rabal, Noelia Casares, Alejandra Bernardini, Cristian Suarez-Cabrera, Fernando F López-Calderón, Puri Fortes, José A Casado, Marta Dueñas, Felipe Villacampa, Juan Jose Lasarte, Félix Guerrero-Ramos, Guillermo de Velasco, Julen Oyarzabal, Daniel Castellano, Xabier Agirre, Felipe Prosper, Jesus M Paramio
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression. Nature medicine 25 (7) (2019)
Marcos Vasquez, Marta Consuegra-Fernández, Fernando Aranda, Aitor Jimenez, Shirley Tenesaca, Myriam Fernandez-Sendin, Celia Gomar, Nuria Ardaiz, Claudia Augusta Di Trani, Noelia Casares, Juan Jose Lasarte, Francisco Lozano, Pedro Berraondo
Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α. Journal of immunology (Baltimore, Md. : 1950) 203 (3) (2019)
Marién Pascual, María Mena-Varas, Eloy Francisco Robles, Maria-Jose Garcia-Barchino, Carlos Panizo, Sandra Hervás-Stubbs, Diego Alignani, Ainara Sagardoy, Jose Ignacio Martinez-Ferrandis, Karen L Bunting, Stephen Meier, Xavier Sagaert, Davide Bagnara, Elisabeth Guruceaga, Oscar Blanco, Jon Celay, Alvaro Martínez-Baztan, Noelia Casares, Juan Jose Lasarte, Thomas MacCarthy, Ari M Melnick, Jose-Angel Martinez-Climent, Sergio Roa
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas. Blood 133 (22) (2019)
Diana Llopiz, Marta Ruiz, Lorea Villanueva, Tamara Iglesias, Leyre Silva, Josune Egea, Juan Jose Lasarte, Perrine Pivette, Véronique Trochon-Joseph, Bérangère Vasseur, Graham Dixon, Bruno Sangro, Pablo Sarobe
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model. Cancer immunology, immunotherapy : CII 68 (3) (2018)
Teresa Lozano, Lorea Villanueva, Maika Durántez, Marta Gorraiz, Marta Ruiz, Virginia Belsúe, José I Riezu-Boj, Sandra Hervás-Stubbs, Julen Oyarzábal, Hozefa Bandukwala, Ana R Lourenço, Paul J Coffer, Pablo Sarobe, Jesús Prieto, Noelia Casares, Juan Jose Lasarte
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation. Journal of immunology (Baltimore, Md. : 1950) 195 (7) (2015)

Juan Jose Lasarte.css-eqlu8i{font-size:small;padding-left:4px;} (Juan J Lasarte, J J Lasarte, Juan José Lasarte, Juan Lasarte)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan Jose Lasarte (Juan J Lasarte, J J Lasarte, Juan José Lasarte, Juan Lasarte)